Access cutting-edge brain tumors treatment through this clinical trial at a research site in Boston. Study-provided care at no cost to qualified participants.
Access brain tumors specialists in Boston at no cost
This study follows strict safety protocols and ethical guidelines
All study-related brain tumors treatment provided free
Indoximod was developed to inhibit the IDO (indoleamine 2,3-dioxygenase) enzymatic pathway, which is important in the natural regulation of immune responses. This potent immune suppressive mechanism has been implicated in regulating immune responses in settings as diverse as infection, tissue/organ transplant, autoimmunity, and cancer. By inhibiting the IDO pathway, we hypothesize that indoximod will improve antitumor immune responses and thereby slow the growth of tumors. The central clinical
Sponsor: Theodore S. Johnson
Check if you qualify for this brain tumors clinical trial in Boston, MA
If you're searching for brain tumors treatment options in Boston, MA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Boston research site is actively enrolling participants for this clinical trial. You'll receive care from experienced brain tumors specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.